These observations complement the findings of previous studies showing that PRL treatment (19) and long-term pancreatic-induced expression of mouse placental lactogen-1 (42) counteract STZ-induced hyperglycemia, but where the underlying physiology resulting in lowered glucose levels was not defined. Here, PRL is linked to Hyperglycemia.